Exela Holdings

Exela Pharma Sciences is a specialty pharmaceutical company focused on the development, manufacturing, and marketing of generic and proprietary sterile injectable and ophthalmic products. Headquartered in Lenoir, North Carolina, the company operates as a fully integrated organization with extensive R&D and CGMP manufacturing capabilities. Exela specializes in the 505(b)(2) regulatory pathway, which allows for the approval of improved versions of existing drugs. In addition to its own product portfolio, the company provides contract development and manufacturing (CDMO) services to global pharmaceutical partners. Their therapeutic focus includes critical care, anesthesia, pain management, and clinical nutrition.